Envision Healthcare (NYSE:EVHC)‘s stock had its “hold” rating reaffirmed by stock analysts at Cantor Fitzgerald in a research report issued on Wednesday. They presently have a $37.00 price target on the stock. Cantor Fitzgerald’s price objective would suggest a potential downside of 1.75% from the company’s previous close.
The analysts wrote, “Revised 2018 estimates. We are lowering our 2018 adjusted EPS estimate to $3.75 from $3.95 and bringing down our adjusted 2018 EBITDA estimate to $950.6 million from $982 million to account for slightly higher seasonality, primarily in terms of salary, wages and benefits, which account for the majority of EVHC’s operating expenses. Our new estimate is just below the $960 million midpoint of management’s potential 2018 performance, as outlined in a presentation last November, but it remains above the $925.1 million FactSet consensus.””
Several other research firms have also commented on EVHC. Oppenheimer decreased their price target on shares of Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating for the company in a report on Thursday, November 2nd. Jefferies Group set a $41.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Tuesday, December 19th. Stephens reaffirmed a “hold” rating and issued a $34.00 price target on shares of Envision Healthcare in a report on Wednesday, January 10th. Bank of America lowered shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $32.00 price target for the company. in a report on Thursday, November 2nd. Finally, ValuEngine lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. One analyst has rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $41.83.
Envision Healthcare (NYSE EVHC) opened at $37.66 on Wednesday. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $72.96. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. The company has a market cap of $4,540.00, a PE ratio of -25.28, a PEG ratio of 0.96 and a beta of 0.57.
A number of institutional investors have recently bought and sold shares of the business. Maverick Capital Ltd. boosted its stake in Envision Healthcare by 30.7% during the 4th quarter. Maverick Capital Ltd. now owns 10,002,182 shares of the company’s stock valued at $345,675,000 after purchasing an additional 2,349,648 shares during the period. BlackRock Inc. boosted its stake in Envision Healthcare by 6.5% during the 4th quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock valued at $277,462,000 after purchasing an additional 487,314 shares during the period. Janus Henderson Group PLC boosted its stake in Envision Healthcare by 0.3% during the 3rd quarter. Janus Henderson Group PLC now owns 3,958,329 shares of the company’s stock valued at $177,927,000 after purchasing an additional 13,242 shares during the period. OZ Management LP acquired a new position in Envision Healthcare during the 3rd quarter valued at about $131,987,000. Finally, Dimensional Fund Advisors LP boosted its stake in Envision Healthcare by 21.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,986,612 shares of the company’s stock valued at $89,289,000 after purchasing an additional 352,654 shares during the period.
COPYRIGHT VIOLATION WARNING: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/23/envision-healthcare-evhc-rating-reiterated-by-cantor-fitzgerald.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.